Apeloa Pharmaceutical Co. Ltd. Class A 000739

SZSE · China · Health Technology

CNY 27.74+1.18 (+4.44%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Apeloa Pharmaceutical Co. Ltd. Class A 000739

SZSE · China · Health Technology

CNY 27.74+1.18 (+4.44%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

+55.15% · 6MFull-screen chart

Open CNY 25.77High CNY 27.89Low CNY 25.23Close CNY 27.74Volume 21.58M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CNY 26.56
Day range: CNY 25.23 – CNY 27.89
52-week range: CNY 14.89 – CNY 27.89
Volume: 21.86M
Market cap: CNY 32.14B
P/E (TTM): 37.6
Dividend yield (annualized): 2.11%
Next earnings date: 2026-10-16
Avg. volume (1Y): 13.22M

Performance

1 week

+1.70%

1 month

+18.77%

3 months

+45.15%

6 months

+48.18%

Year to date

+59.90%

1 year

+59.22%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: China
Exchange: SZSE
Shares outstanding: 1.13B
Employees: 6,787
ISIN: CNE000000Q45
Beta: 0.96

Technical view

Above averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceSep 17, 2026

Apeloa Honored with Frost & Sullivan's 2026 Global CDMO Company of the Year Award

Global GIL Recognition Spotlights Apeloa’s End-to-End "API + Drug Product" Integration, Advanced Technology Platforms, and Its Compliance Track Record in Regulated MarketsSHANGHAI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Apeloa Pharmaceutical Co., Ltd. (Apeloa; SZSE: 000739.SZ), a leading contract development and manufacturing organization (CDMO) and technology-driven pharmaceutical manufacturer, announced that it has been awarded the “2026 Global CDMO Company of the Year Award” by growth advisory fi

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.